-Ishwarlal Jialal Researcher Activity Profile

Research Author Detailed Information 

Ishwarlal Jialal Publication Rate By Year

Ishwarlal Jialal has published 1 paper(s) in 1995, 1 paper(s) in 1996, 1 paper(s) in 2005, 4 paper(s) in 2006, 16 paper(s) in 2007, 2 paper(s) in 2008, for a total of 25 research publications in total.

Ishwarlal I Jialal Author Information

LAST NAME: jialal

FIRST NAME: Ishwarlal

INITIALS: i

AFFILIATION:

Papers

Ishwarlal Jialal's Publication Record

1. Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results. Year Published: 2007
Department of Pathology and Laboratory Medicine, University of California, Davis, School of Medicine, CA, USA.
2. RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Year Published: 1996
Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas 75235-9052, USA.
3. Therapy and clinical trials. Year Published: 2005
4. Oxidative stress and atherosclerosis. Year Published: 2006
The Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, Sacramento, CA, United States.
5. The effect of weight loss and dietary fatty acids on inflammation. Year Published: 2006
VA Northern California Health System, Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, Sacramento, CA 95817, USA.
6. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. Year Published: 2006
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis, Medical Center and Veterans Affairs Medical Center, Sacramento, California 95817, USA.
7. Statins and biomarkers of inflammation. Year Published: 2006
8. The role of C-reactive protein activation of nuclear factor kappa-B in the pathogenesis of unstable angina. Year Published: 2007
9. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, CA, USA.
10. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Year Published: 2007
University of California Davis Medical Center, Sacramento, California 95817, USA.
11. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis, Medical Center, Sacramento, California 95817, USA. ishwarlal.jialal@ucdmc.ucdavis.edu
12. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
13. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Year Published: 2007
Department of Pathology, Laboratory for Atherosclerosis and Metabolic Research, UCDavis Medical Center, Sacramento, CA 95817, USA. sdevaraj@ucdavis.edu
14. Effect of high-dose {alpha}-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Year Published: 2007
University of Texas Southwestern Medical Center, Dallas, TX.
15. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Year Published: 2007
Department of Pathology, Laboratory for Atherosclerosis and Metabolic Research, UCDavis Medical Center, Sacramento, CA 95817, USA. sdevaraj@ucdavis.edu
16. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Year Published: 2007
University of Texas Southwestern Medical Center, Dallas, TX, USA.
17. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical, Center, Sacramento CA 95817, USA.
18. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
19. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Year Published: 2007
University of Texas Southwestern Medical Center, Dallas, TX, USA.
20. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
21. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, University of California-Davis, 4635 2nd Avenue, Sacramento, CA 95817, USA.
22. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, University of California-Davis, 4635 2nd Avenue, Sacramento, CA 95817, USA.
23. Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State. Year Published: 2008
Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, 4635 II Avenue, Research I Building, Room 3000, Sacramento, California 95817. ijialal@ucdavis.edu.
24. Editorial. Year Published: 2008
25. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Year Published: 1995
Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235-9052, USA.